To Facilitate Funds to find Crispr based cures as soon as possible.
To Facilitate awareness of Crispr Cures the minute they are approved by the FDA.–(In December of 2023 the FDA approved the first Crispr Cure for Sickle Cell Anemia)
To provide high quality, low cost, nitrile gloves to health care facilities.